{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:07:28Z","timestamp":1763626048987,"version":"3.45.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"am","delay-in-days":328,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resinv.2025.09.016","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:01:29Z","timestamp":1758787289000},"page":"1194-1200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer"],"prefix":"10.1016","volume":"63","author":[{"given":"Megumi","family":"Mizutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7245-4990","authenticated-orcid":false,"given":"Kenji","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0620-4957","authenticated-orcid":false,"given":"Hiroaki","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6584-1673","authenticated-orcid":false,"given":"Yoshiya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7696-2391","authenticated-orcid":false,"given":"Hiroyasu","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3304-5980","authenticated-orcid":false,"given":"Tsubasa","family":"Bito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.resinv.2025.09.016_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1158\/2326-6066.CIR-16-0237","article-title":"Comprehensive meta-analysis of key immune-related adverse events from CTLA-4 and PD-1\/PD-L1 inhibitors in cancer patients","volume":"5","author":"De Velasco","year":"2017","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"10.1016\/j.resinv.2025.09.016_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chest.2017.04.177","article-title":"Incidence of pneumonitis with use of programmed death 1 and programmed death-ligand 1 inhibitors in non-small cell lung cancer: a systematic review and meta-analysis of trials","volume":"152","author":"Khunger","year":"2017","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.resinv.2025.09.016_bib3","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.jtho.2018.08.2035","article-title":"Pneumonitis in non-small cell lung cancer patients receiving immune checkpoint immunotherapy: incidence and risk factors","volume":"13","author":"Suresh","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"8","key":"10.1016\/j.resinv.2025.09.016_bib4","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1183\/09031936.97.10081907","article-title":"Pleural diseases related to metastatic malignancies","volume":"10","author":"Sahn","year":"1997","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"10.1016\/j.resinv.2025.09.016_bib5","doi-asserted-by":"crossref","first-page":"ii29","DOI":"10.1136\/thx.58.suppl_2.ii29","article-title":"BTS guidelines for the management of malignant pleural effusions","volume":"58","author":"Antunes","year":"2003","journal-title":"Thorax"},{"issue":"9572","key":"10.1016\/j.resinv.2025.09.016_bib6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(07)60708-9","article-title":"Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study","volume":"369","author":"Janssen","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.resinv.2025.09.016_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9610(99)00075-6","article-title":"Respiratory failure following talc pleurodesis","volume":"177","author":"Rehse","year":"1999","journal-title":"Am J Surg"},{"issue":"14","key":"10.1016\/j.resinv.2025.09.016_bib8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2169\/internalmedicine.56.7464","article-title":"Interstitial lung disease after pleurodesis for malignant pleural effusion","volume":"56","author":"Yokoe","year":"2017","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.resinv.2025.09.016_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.resinv.2017.11.006","article-title":"Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis","volume":"56","author":"Sakata","year":"2018","journal-title":"Respir Investig"},{"year":"2023","series-title":"Press release: updated database information","key":"10.1016\/j.resinv.2025.09.016_bib10"},{"issue":"7","key":"10.1016\/j.resinv.2025.09.016_bib11","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s12325-020-01392-0","article-title":"Treatment sequencing in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer in Japan: a real-world observational study","volume":"37","author":"Goto","year":"2020","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.resinv.2025.09.016_bib12","article-title":"Real-world evidence of diagnostic testing for driver oncogene mutations in lung cancer in Japan","volume":"2","author":"Yatabe","year":"2021","journal-title":"JTO Clin Res Rep"},{"issue":"2","key":"10.1016\/j.resinv.2025.09.016_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cllc.2023.11.003","article-title":"Lack of Association between immunotherapy and improvement of survival for non-small cell lung cancer patients with hemodialysis: a nationwide retrospective cohort Study","volume":"25","author":"Sawa","year":"2024","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"10.1016\/j.resinv.2025.09.016_bib14","first-page":"730","article-title":"Renin-angiotensin-aldosterone system inhibitors are associated with improved paclitaxel-induced peripheral neuropathy in lung cancer: a study using administrative claims data","volume":"31","author":"Ihara","year":"2023","journal-title":"Support Care Cancer"},{"issue":"12","key":"10.1016\/j.resinv.2025.09.016_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29917","article-title":"Lung cancer survival in patients with autoimmune disease","volume":"3","author":"Jacob","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.resinv.2025.09.016_bib16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.resinv.2025.09.016_bib17","first-page":"61","article-title":"Functional EVALUATION: the BARTHEL INDEX","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"issue":"3","key":"10.1016\/j.resinv.2025.09.016_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1541-0420.2005.00356.x","article-title":"Propensity score matching with time-dependent covariates","volume":"61","author":"Lu","year":"2005","journal-title":"Biometrics"},{"issue":"455","key":"10.1016\/j.resinv.2025.09.016_bib19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1198\/016214501753208573","article-title":"Balanced risk set matching","volume":"96","author":"Li","year":"2001","journal-title":"J Am Stat Assoc"},{"issue":"25","key":"10.1016\/j.resinv.2025.09.016_bib20","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"year":"2021","series-title":"R: a language and environment for statistical computing","key":"10.1016\/j.resinv.2025.09.016_bib21"},{"issue":"19","key":"10.1016\/j.resinv.2025.09.016_bib23","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-Positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.resinv.2025.09.016_bib24","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"issue":"41","key":"10.1016\/j.resinv.2025.09.016_bib25","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.18632\/oncotarget.27750","article-title":"Evaluation of cellular alterations and inflammatory profile of mesothelial cells and\/or neoplastic cells exposed to talc used for pleurodesis","volume":"11","author":"Acencio","year":"2020","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.resinv.2025.09.016_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2169\/internalmedicine.34.352","article-title":"OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion","volume":"34","author":"Kataoka","year":"1995","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.resinv.2025.09.016_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.resinv.2025.09.016_bib28","article-title":"Peripheral blood biomarkers for early diagnosis, severity, and prognosis of checkpoint inhibitor-related pneumonitis in patients with lung cancer","volume":"11","author":"Lin","year":"2021","journal-title":"Front Oncol"},{"issue":"36","key":"10.1016\/j.resinv.2025.09.016_bib29","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune Checkpoint Inhibitor Therapy: ASCO Guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.resinv.2025.09.016_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00262-022-03281-7","article-title":"Risk of pneumonitis in non-small cell lung cancer patients with preexisting interstitial lung diseases treated with immune checkpoint inhibitors: a nationwide retrospective cohort study","volume":"72","author":"Sawa","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.resinv.2025.09.016_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/pds.4374","article-title":"Bias from outcome misclassification in immunization schedule safety research","volume":"27","author":"Newcomer","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.resinv.2025.09.016_bib32","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2016.68.2005","article-title":"Pneumonitis in patients treated with anti-programmed Death-1\/Programmed death ligand 1 therapy","volume":"35","author":"Naidoo","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525001522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:03:01Z","timestamp":1763625781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2212534525001522"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.09.016","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}